143 filings
Page 4 of 8
8-K
tn7oyv kidepq98ggqv
15 Apr 21
Other Events
4:15pm
8-K
rq6qqgdj9x54k7rd
11 Mar 21
Selecta Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
8:01am
8-K
bwjd2sl04f33yv713mhu
6 Jan 21
Selecta Biosciences Announces Data in Non-Human Primates, Further Validating Multiple Potential Benefits of the ImmTORTM Platform in Gene Therapy
8:15am
8-K
eddlcz0xhypvm7lo
5 Nov 20
Selecta Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
8:02am
8-K
c5z i0gz6
8 Oct 20
Other Events
4:15pm
8-K
cn9p0f
30 Sep 20
Results of Operations and Financial Condition
4:32pm
8-K
frany nkz
3 Sep 20
Entry into a Material Definitive Agreement
4:30pm
8-K
3h893xtha2ro38zetr
6 Aug 20
Entry into a Material Definitive Agreement
5:16pm
8-K
7my72 tja
6 Aug 20
Selecta Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Updates
8:00am
8-K
k4slf7n pd35nn11ux59
25 Jun 20
Departure of Directors or Certain Officers
4:30pm
8-K
ckts7 oqo
22 Jun 20
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
o4a496gdlo
18 Jun 20
Corporate Presentation J u n e 2 0 2 0 SELB
8:50am
8-K
ai9o0i kn0qudzyrsw
18 Jun 20
Entry into a Material Definitive Agreement
8:45am
8-K
egvbb3 gs
12 Jun 20
Entry into a Material Definitive Agreement
12:00am
8-K
xbxxg5x
7 May 20
Selecta Biosciences Reports First Quarter 2020 Financial Results
8:00am
8-K
425y9tzulf6y29
27 Apr 20
Departure of Directors or Certain Officers
4:30pm
8-K
7zqdgkcodjow
31 Mar 20
Other Events
8:32am
8-K
7032j qql9b7
12 Mar 20
Selecta Biosciences Reports Fourth Quarter 2019 and Year-End Financial Results
8:10am
8-K
mqfctdl
13 Jan 20
Corporate Presentation January 2020 SELB
8:15am
8-K
ay9zx7y2 xgdaf
26 Dec 19
Entry into a Material Definitive Agreement
6:05am